Cited by 1,602Sirtuins and Resveratrol in MedicineAdipose Tissue and MetabolismMetabolism, Diabetes, and Cancer

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

Open access
Price, Nathan L., Gomes, Ana P., Ling, Alvin J.Y., Duarte, Filipe V., Martin-Montalvo, Alejandro, North, Brian J., Agarwal, Beamon, Ye, Lan +14 more·2012·Cell Metabolism

Abstract

Resveratrol induces mitochondrial biogenesis and protects against metabolic decline, but whether SIRT1 mediates these benefits is the subject of debate. To circumvent the developmental defects of germline SIRT1 knockouts, we have developed an inducible system that permits whole-body deletion of SIRT1 in adult mice. Mice treated with a moderate dose of resveratrol showed increased mitochondrial biogenesis and function, AMPK activation, and increased NAD(+) levels in skeletal muscle, whereas SIRT1 knockouts displayed none of these benefits. A mouse overexpressing SIRT1 mimicked these effects. A high dose of resveratrol activated AMPK in a SIRT1-independent manner, demonstrating that resveratrol dosage is a critical factor. Importantly, at both doses of resveratrol no improvements in mitochondrial function were observed in animals lacking SIRT1. Together these data indicate that SIRT1 plays an essential role in the ability of moderate doses of resveratrol to stimulate AMPK and improve mitochondrial function both in vitro and in vivo.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2012.04.003

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Resveratrol can inhibit the activity of phosphodiesterases (PDE), particularly PDE4, thus increasing intracellular cAMP.

    “As for other mechanisms of action of resveratrol, experimental evidence has shown that this polyphenol can inhibit the activity of phosphodiesterases (PDE) and in particular of the PDE4 isoform, thus increasing the intracellular levels of cyclic adenosine monophosphate (cAMP) [17].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [17]

  • In a SIRT-1 knock-out mouse model, resveratrol is unable to induce AMPK phosphorylation at a low dose, but AMPK phosphorylation is observed at a 10 times higher dose.

    “Indeed, in a SIRT-1 knock-out mouse model, resveratrol is unable to induce AMPK phosphorylation at a low dose. In contrast, AMPK phosphorylation was observed at 10 times higher dose.”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [17]

  • Resveratrol can phosphorylate AMPK in a dose-dependent manner and independently of SIRT-1.

    “These results, therefore, indicate that resveratrol can phosphorylate AMPK in a dose-dependent manner and independently of SIRT-1 [17].”

    From The Role of Resveratrol Administration in Human Obesity (2021) · cites this paper as [17]

  • Sirtuin-regulated mitochondrial activity acts directly on stem cells and also indirectly alters ROS and nutrient sensing, further changing stem cell phenotypes.

    “Likewise, mitochondrial function, largely regulated by sirtuins, not only affects stem cell functions directly but also causes secondary effects on ROS and nutrient-sensing activities, which further modulate stem cell phenotypes29,30,108,113,184.”
  • AMPK and SIRT1 participate in a positive feedback loop that engages both sensors of low-energy states into a univocal response.

    “Notably, AMPK and SIRT1 participate in a positive feedback loop that engages both sensors of low-energy states into a univocal response.227”

    From Meta-hallmarks of aging and cancer (2023) · cites this paper as [227]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Price, N. L., Gomes, A. P., Ling, A. J. Y., Duarte, F. V., Martin-Montalvo, A., North, B. J., Agarwal, B., Ye, L., Ramadori, G., Teodoro, J. S., Hubbard, B. P., Varela, A. T., Davis, J. G., Varamini, B., Hafner, A., Moaddel, R., Rolo, A. P., Coppari, R., Palmeira, C. M., de Cabo, R., Baur, J. A., & Sinclair, D. A.
Affiliations
  • Harvard University (US)
  • Centro de Neurociências e Biologia Celular (PT)
  • University of Pennsylvania (US)
  • The University of Texas Southwestern Medical Center (US)
  • National Institutes of Health (US)
  • Marche Polytechnic University (IT)
Corresponding author
Sinclair, David A.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2012-05
Volume
15
Issue
5
Pages
675-690
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2078575160
Cited by
1,602
References
103
Citations by year
2026: 99 · 2025: 103 · 2024: 115 · 2023: 86 · 2022: 120 · 2021: 139 · 2020: 130 · 2019: 121 · 2018: 87 · 2017: 124 · 2016: 98 · 2015: 121 · 2014: 120 · 2013: 92 · 2012: 43
FWCI
59.14
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
Funders
  • National Institutes of Health
  • National Institute on Aging (R37AG028730, P01AG027916, R01AG028730, R01AG019719)
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK080836, R01DK080836)
  • National Center for Research Resources
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords
SIRT1, AMPK activation, resveratrol, mitochondrial biogenesis, mitochondrial function, NAD levels, skeletal muscle, SIRT1 overexpression, dose-dependent effects, metabolic decline
MeSH terms
Resveratrol, AMP-Activated Protein Kinase Kinases, Animals, Cells, Cultured, Enzyme Activation, Mice, Inbred C57BL, Mitochondria, NAD, Protein Kinases, Stilbenes, Signal Transduction, Mice, Knockout, Muscle, Skeletal, Hepatocytes, Mice, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review